266
Views
2
CrossRef citations to date
0
Altmetric
Review

A systematic review and meta-analysis: the diagnostic accuracy of methylated SEPTIN9 for the detection of hepatocellular carcinoma and the clinical evaluation of its use in combination with other surveillance modalities

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 473-480 | Received 25 Oct 2021, Accepted 15 Dec 2021, Published online: 25 Dec 2021

References

  • International Agency for Research on Cancer; Liver; World Health Organization; [cited 2021 Aug 1]. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf
  • Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250–261.
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
  • Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462.
  • Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. Epub 2018 Apr 5. Erratum in: J Hepatol. 2019 Apr;70(4):817.
  • Overview | Cirrhosis in over 16s: assessment and management | Guidance | NICE [Internet]. [cited 2021 Aug 19]. Available from: https://www.nice.org.uk/guidance/ng50
  • Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750.
  • Gopal P, Yopp AC, Waljee AK, et al. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12(5):870–877.
  • Singal A, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30(1):37–47.
  • Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018;67(1):401–421.
  • Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.
  • Chen M, Zhao H. Next-generation sequencing in liquid biopsy: cancer screening and early detection. Hum Genomics. 2019;13(1):34.
  • Epi ProColon. [cited 2021 Aug 1]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf13/p130001c.pdf
  • Sun J, Zheng MY, Li YW, et al. Structure and function of Septin 9 and its role in human malignant tumors. World J Gastrointest Oncol. 2020;12(6):619–631.
  • Wu Y, Bu F, Yu H, et al. Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis. Toxicol Appl Pharmacol. 2017;315:35–49.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Bristol U of. QUADAS-2 | Bristol Medical School: Population Health Sciences | University of Bristol. 2020.
  • The R Foundation. R: The R Project for Statistical Computing [Internet]. 2018 [cited 2021 Aug 19]. Available from: https://www.r-project.org/
  • Doebler P, Holling H. Meta-Analysis of Diagnostic Accuracy with mada [Internet]. 2012 [cited 2021 Aug 19]. p. 1–15. Available from: http://r-forge.r-project.org/projects/mada/
  • Colli A, Nadarevic T, Miletic D, Cochrane Hepato-Biliary Group, et al. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2021;2021(4):CD013346.
  • Bannaga AS, Alvarez R, Zhou L, et al. Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma. HPB. 2021;23(10):1595–1606.
  • He N, Feng G, Zhang C, et al. Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis. Mol Med Rep. 2020;22(4):2705–2714.
  • Li B, Huang H, Huang R, et al. SEPT9 gene methylation as a noninvasive marker for hepatocellular carcinoma. Dis Markers. 2020;2020:6289063.
  • Kotoh Y, Suehiro Y, Saeki I, et al. Novel liquid biopsy test based on a sensitive methylated SEPT9 assay for diagnosing hepatocellular carcinoma. Hepatol Commun. 2020;4(3):461–470.
  • Lewin J, Kottwitz D, Aoyama J, et al. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. BMC Gastroenterol. 2021;21(1):136.
  • Oussalah A, Rischer S, Bensenane M, et al. Plasma mSEPT9: a novel circulating cell-free DNA-based epigenetic biomarker to diagnose hepatocellular carcinoma. EBioMedicine. 2018;30:138–147.
  • Singal AG, Hoshida Y, Pinato DJ, et al. International liver cancer association (ILCA) white paper on biomarker development for hepatocellular carcinoma. Gastroenterology. 2021;160(7):2572–2584.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.